Publication | Closed Access
Cutaneous ulcers with type I cryoglobulinemia treated with plasmapheresis.
17
Citations
0
References
2004
Year
VasculitisImmunologyPathologyDermatologyImmunotherapyPlasma MedicineInflammationHematologyCutaneous UlcersAutoantibodiesAutoimmune DiseaseSystemic Lupus Erythematosus TreatmentAutoimmunityImmunologic DiseaseDermatopathologyLupusKidney InvolvementMultiple MyelomaWound HealingImmunosuppressionCryoglobulin LevelsMedicineCryoglobulinemia
Severe necrotic cutaneous ulcers and kidney involvement secondary to type I cryoglobulinemia can be a therapeutic challenge. Plasmapheresis has been reported useful to treat autoimmune diseases such as thrombotic thrombocytopenic purpura, systemic lupus erythematosus, myasthenia gravis and Goodpasture's syndrome. We report the case of a patient who presented necrotic lesions with kidney involvement due to type I cryoglobulinemia (Ig G kappa) that evolved to a multiple myeloma. Treatment with high doses of corticosteroid plus cyclophosphamide did not control the disorder. Therapy with plasmapheresis produced a marked decrease in cryoglobulin levels and a subsequent relevant clinical improvement of cutaneous lesions and renal function. In cryoglobulinemia, plasmapheresis can be used as effective adjunt therapy to minimize cutaneous, renal and/or neurologic involvement.